Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial
Shimada, K; Yamaguchi, M; Atsuta, Y; Matsue, K; Sato, K; Kusumoto, S; Nagai, H; Takizawa, J; Fukuhara, N; Nagafuji, K; Miyazaki, K; Ohtsuka, E; Okamoto, M; Sugita, Y; Uchida, T; Kayukawa, S; Wake, A; Ennishi, D; Kondo, Y; Izumi, T; Kin, Y; Tsukasaki, K; Hashimoto, D; Yuge, M; Yanagisawa, A; Kuwatsuka, Y; Shimada, S; Masaki, Y; Niitsu, N; Kiyoi, H; Suzuki, R; Tokunaga, T; Nakamura, S; Kinoshita, T
Shimada, K (corresponding author), Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi 4668550, Japan.
LANCET ONCOLOGY, 2020; 21 (4): 593
